MetLife Investment Advisors »

Akebia Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Akebia Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akebia Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akebia Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $369k 135k 2.73
2025-06-30 $545k 150k 3.64
2025-03-31 $227k 118k 1.92
2024-12-31 $198k 104k 1.90
2024-09-30 $90k 68k 1.32
2024-06-30 $55k 54k 1.02
2022-03-31 $61k 85k 0.72
2021-12-31 $70k 31k 2.26
2021-09-30 $184k 64k 2.88
2021-06-30 $123k 33k 3.79
2021-03-31 $206k 61k 3.39
2020-12-31 $90k 32k 2.80
2020-09-30 $71k 28k 2.51
2020-06-30 $790k 58k 13.58
2020-03-31 $396k 52k 7.58
2019-12-31 $263k 42k 6.32
2019-09-30 $225k 57k 3.92
2019-06-30 $197k 41k 4.84
2019-03-31 $333k 41k 8.20
2018-12-31 $225k 41k 5.54
2018-09-30 $339k 38k 8.84
2018-06-30 $214k 21k 9.99
2018-03-31 $204k 21k 9.52
2017-12-31 $319k 21k 14.89